Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$2.48B |
| 2 |
Wells Fargo
WFC
|
+$2.4B |
| 3 |
NVIDIA
NVDA
|
+$2.03B |
| 4 |
American Express
AXP
|
+$948M |
| 5 |
Amazon
AMZN
|
+$855M |
Top Sells
| 1 |
Pfizer
PFE
|
+$1.71B |
| 2 |
Chubb
CB
|
+$1.57B |
| 3 |
ConocoPhillips
COP
|
+$1.49B |
| 4 |
Microsoft
MSFT
|
+$1.37B |
| 5 |
Advanced Micro Devices
AMD
|
+$1.15B |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Healthcare | 20.37% |
| 3 | Financials | 14.37% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1551
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $1.17M | ﹤0.01% |
15,000
| – | – |
|
1552
Agios Pharmaceuticals
AGIO
$2.12B
| $1.17M | ﹤0.01% |
39,844
-5,623
| -12% | -$164K |
|
1553
Cullinan Oncology
CGEM
$404M
| $1.16M | ﹤0.01% |
+68,358
| New | +$1.16M |
|
1554
Arbutus Biopharma
ABUS
$784M
| $1.16M | ﹤0.01% |
+451,305
| New | +$1.16M |
|
|
CSTR
1555
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.16M | ﹤0.01% |
57,818
-9,748
| -14% | -$196K |
|
1556
Heron Therapeutics
HRTX
$199M
| $1.16M | ﹤0.01% |
+417,985
| New | +$1.16M |
|
1557
J.M. Smucker
SJM
$11.9B
| $1.16M | ﹤0.01% |
9,197
-551
| -6% | -$69.4K |
|
1558
ARS Pharmaceuticals
SPRY
$1.06B
| $1.16M | ﹤0.01% |
+113,205
| New | +$1.16M |
|
|
PSTX
1559
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.14M | ﹤0.01% |
+356,896
| New | +$1.14M |
|
1560
iShares MSCI UAE ETF
UAE
$164M
| $1.14M | ﹤0.01% |
76,784
+35,551
| +86% | +$526K |
|
1561
Terns Pharmaceuticals
TERN
$637M
| $1.13M | ﹤0.01% |
+172,599
| New | +$1.13M |
|
1562
Tango Therapeutics
TNGX
$758M
| $1.12M | ﹤0.01% |
140,995
-29,233
| -17% | -$232K |
|
1563
International Flavors & Fragrances
IFF
$17B
| $1.12M | ﹤0.01% |
13,006
+1,884
| +17% | +$162K |
|
1564
Timken Company
TKR
$5.37B
| $1.12M | ﹤0.01% |
12,788
-2,739
| -18% | -$239K |
|
1565
WESCO International
WCC
$10.6B
| $1.12M | ﹤0.01% |
6,519
-197,120
| -97% | -$33.8M |
|
1566
DocuSign
DOCU
$16.5B
| $1.11M | ﹤0.01% |
18,664
+9,149
| +96% | +$545K |
|
|
GTY
1567
Getty Realty Corp
GTY
$1.62B
| $1.11M | ﹤0.01% |
40,439
-1,868
| -4% | -$51.1K |
|
1568
Arcellx
ACLX
$3.94B
| $1.09M | ﹤0.01% |
15,697
+1,628
| +12% | +$113K |
|
1569
American Financial Group
AFG
$11.5B
| $1.09M | ﹤0.01% |
7,995
+637
| +9% | +$86.9K |
|
1570
Vericel Corp
VCEL
$1.68B
| $1.09M | ﹤0.01% |
+20,969
| New | +$1.09M |
|
1571
Beam Therapeutics
BEAM
$2.02B
| $1.09M | ﹤0.01% |
32,953
+12,037
| +58% | +$398K |
|
|
EDR
1572
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $1.09M | ﹤0.01% |
42,306
+5,040
| +14% | +$130K |
|
1573
Steris
STE
$24.5B
| $1.08M | ﹤0.01% |
4,809
-373
| -7% | -$83.9K |
|
|
TSVT
1574
DELISTED
2seventy bio
TSVT
| $1.08M | ﹤0.01% |
202,073
-313,882
| -61% | -$1.68M |
|
1575
Acadia Pharmaceuticals
ACAD
$4.28B
| $1.08M | ﹤0.01% |
58,267
+19,280
| +49% | +$356K |
|